Gene · 406891
Papers2,321
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,321
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Circulating and Endometrial Tissue microRNA Markers Associated with Endometrial Cancer Diagnosis, Prognosis, and Response to Treatment. | Cancers (Basel) | 2023 | 37345024 | PubTator, text mining | PubMed |
| The LIN28B-let-7-PBK pathway is essential for group 3 medulloblastoma tumor growth and survival. | Mol Oncol | 2023 | 37341142 | PubTator, text mining | PubMed |
| DICER1 platform domain missense variants inhibit miRNA biogenesis and lead to tumor susceptibility. | NAR Cancer | 2023 | 37333613 | PubTator, text mining | PubMed |
| A Review of micro RNAs changes in T2DM in animals and humans. | J Diabetes | 2023 | 37329278 | PubTator, text mining | PubMed |
| A novel 3-miRNA network regulates tumour progression in oral squamous cell carcinoma. | Biomark Res | 2023 | 37316916 | PubTator, text mining | PubMed |
| miR-372-3p is a potential diagnostic factor for diabetic nephropathy and modulates high glucose-induced glomerular endothelial cell dysfunction via targeting fibroblast growth factor-16. | Arch Med Sci | 2023 | 37313198 | PubTator, text mining | PubMed |
| The role of LIN28B in tumor progression and metastasis in solid tumor entities. | Oncol Res | 2023 | 37304235 | PubTator, text mining | PubMed |
| miRNA-Guided Regulation of Mesenchymal Stem Cells Derived from the Umbilical Cord: Paving the Way for Stem-Cell Based Regeneration and Therapy. | Int J Mol Sci | 2023 | 37298143 | PubTator, text mining | PubMed |
| Circulating hsa-miR-5096 predicts 18F-FDG PET/CT positivity and modulates somatostatin receptor 2 expression: a novel miR-based assay for pancreatic neuroendocrine tumors. | Front Oncol | 2023 | 37287922 | PubTator, text mining | PubMed |
| Cellular nanovesicles for therapeutic immunomodulation: A perspective on engineering strategies and new advances. | Acta Pharm Sin B | 2023 | 37250173 | PubTator, text mining | PubMed |
| miRNAs, Mesenchymal Stromal Cells and Major Neoplastic and Inflammatory Skin Diseases: A Page Being Written: A Systematic Review. | Int J Mol Sci | 2023 | 37239847 | PubTator, text mining | PubMed |
| Pulmonary Hypertension: New Insights and Recent Advances from Basic Science to Translational Approaches. | Int J Mol Sci | 2023 | 37239809 | PubTator, text mining | PubMed |
| Evaluation and Verification of a microRNA Panel Using Quadratic Discriminant Analysis for the Classification of Human Body Fluids in DNA Extracts. | Genes (Basel) | 2023 | 37239328 | PubTator, text mining | PubMed |
| Dynamic Role of Exosome microRNAs in Cancer Cell Signaling and Their Emerging Role as Noninvasive Biomarkers. | Biology (Basel) | 2023 | 37237523 | PubTator, text mining | PubMed |
| Pharmacological impact of microRNAs in head and neck squamous cell carcinoma: Prevailing insights on molecular pathways, diagnosis, and nanomedicine treatment. | Front Pharmacol | 2023 | 37205904 | PubTator, text mining | PubMed |
| Gastric juice non-coding RNAs as potential biomarkers for gastric cancer. | Front Physiol | 2023 | 37179825 | PubTator, text mining | PubMed |
| Prediction of Early- and Late-Onset Pre-Eclampsia in the Preclinical Stage via Placenta-Specific Extracellular miRNA Profiling. | Int J Mol Sci | 2023 | 37175711 | PubTator, text mining | PubMed |
| Abscopal Effect, Extracellular Vesicles and Their Immunotherapeutic Potential in Cancer Treatment. | Molecules | 2023 | 37175226 | PubTator, text mining | PubMed |
| Selection of endogenous control and identification of significant microRNA deregulations in cervical cancer. | Front Oncol | 2023 | 37168377 | PubTator, text mining | PubMed |
| MicroRNA Let-7i Regulates Innate TLR4 Pathways in Peripheral Blood Mononuclear Cells of Patients with Ankylosing Spondylitis. | Int J Gen Med | 2023 | 37155468 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406891/papers?page=8